Best Combination Blood Pressure Medications
For most patients with hypertension requiring combination therapy, the preferred regimen is a RAS blocker (ACE inhibitor or ARB) combined with a dihydropyridine calcium channel blocker or a thiazide/thiazide-like diuretic, preferably as a single-pill combination. 1
Initial Combination Therapy Strategy
Combination therapy is recommended as initial treatment for most patients with confirmed hypertension (BP ≥140/90 mmHg), with exceptions for patients aged ≥85 years, those with symptomatic orthostatic hypotension, moderate-to-severe frailty, or elevated BP (120-139/70-89 mmHg) with specific indications. 1
Preferred Two-Drug Combinations:
- ACE inhibitor + dihydropyridine calcium channel blocker (e.g., lisinopril + amlodipine) 1, 2, 3
- ARB + dihydropyridine calcium channel blocker (e.g., losartan + amlodipine) 1, 2, 3
- ACE inhibitor + thiazide/thiazide-like diuretic (e.g., lisinopril + chlorthalidone) 1, 2
- ARB + thiazide/thiazide-like diuretic (e.g., losartan + chlorthalidone) 1, 2
Single-pill combinations are strongly recommended over separate pills to improve adherence. 1, 3
Population-Specific Recommendations
Patients with Diabetes and Albuminuria (UACR ≥30 mg/g):
Start with an ACE inhibitor or ARB as the foundation, combined with either a dihydropyridine calcium channel blocker or thiazide-like diuretic. 4, 2, 4 This combination reduces progressive kidney disease risk while controlling blood pressure. 2
- ACE inhibitors and ARBs have superior antiproteinuric effects compared to other antihypertensive classes in diabetic kidney disease. 4
- Either ACE inhibitors or ARBs can be used; they appear equally effective in type 2 diabetes with macroalbuminuria. 4
- Diuretics potentiate the beneficial effects of ACE inhibitors and ARBs in diabetic kidney disease. 4
Patients with Chronic Kidney Disease (eGFR <60 mL/min/1.73 m²):
For patients with albuminuria, use ACE inhibitor or ARB as the base, combined with a loop diuretic (if eGFR <30 mL/min/1.73 m²) or thiazide-like diuretic (if eGFR ≥30 mL/min/1.73 m²). 4
- Continue ACE inhibitor or ARB therapy even as eGFR declines to <30 mL/min/1.73 m², as this may provide cardiovascular benefit without significantly increasing end-stage kidney disease risk. 2
- Thiazide diuretics lose diuretic efficacy when eGFR <30 mL/min/1.73 m², but chlorthalidone may retain some antihypertensive effect through vasodilation. 5
Black Patients:
Initial combination should include a thiazide-type diuretic or calcium channel blocker, as monotherapy with ACE inhibitors or ARBs produces smaller blood pressure reductions in Black patients. 6, 7 However, combining a diuretic with an ACE inhibitor or ARB eliminates racial differences in blood pressure response. 7
Patients with Coronary Artery Disease:
ACE inhibitors or ARBs are recommended as first-line therapy, combined with a dihydropyridine calcium channel blocker or thiazide-like diuretic. 2
Three-Drug Combination Therapy
When BP is not controlled with two drugs, escalate to a three-drug combination: RAS blocker + dihydropyridine calcium channel blocker + thiazide/thiazide-like diuretic, preferably as a single-pill combination. 1, 2, 8
Example regimen: Lisinopril 40 mg + amlodipine 10 mg + chlorthalidone 25 mg daily 8
Critical Contraindications
Never combine an ACE inhibitor with an ARB - this dual RAS blockade increases risks of hyperkalemia, acute kidney injury, and syncope without providing additional cardiovascular benefit. 1, 2, 3, 8
Avoid combining beta-blockers with thiazides as first-line therapy due to increased risk of developing diabetes. 9
Diuretic Selection: Important Nuances
Among thiazide-type diuretics, chlorthalidone is preferred over hydrochlorothiazide based on stronger outcome data and greater potency. 1, 10, 11, 12
- Chlorthalidone 25 mg is more potent than hydrochlorothiazide 50 mg, particularly for overnight blood pressure reduction. 10
- Chlorthalidone demonstrated superiority over lisinopril in preventing stroke and over amlodipine in preventing heart failure in the ALLHAT trial. 10, 11
- Chlorthalidone has pleiotropic effects beyond BP reduction, including favorable effects on cholesterol levels. 12
- Indapamide is an alternative thiazide-like diuretic with no negative impact on glucose or lipid metabolism. 12
Monitoring Requirements
Monitor serum creatinine/eGFR and potassium at baseline, 1-2 weeks after initiation or dose adjustment, and regularly thereafter when using ACE inhibitors, ARBs, or diuretics. 2, 3, 8
Reassess blood pressure 2-4 weeks after medication initiation or adjustment, with a goal of achieving target BP within 3 months. 1, 8
Beta-Blocker Role
Beta-blockers should only be added to combination therapy when there are specific compelling indications: angina, post-myocardial infarction, heart failure with reduced ejection fraction, or heart rate control. 1, 2 They are not recommended as routine antihypertensive agents without these conditions. 2
Resistant Hypertension (Fourth-Line Agent)
If BP remains ≥140/90 mmHg on optimal doses of three drugs (RAS blocker + calcium channel blocker + thiazide diuretic), add spironolactone 25-50 mg daily as the preferred fourth agent. 8 Monitor potassium closely when combining with ACE inhibitor or ARB. 8